ENCLEAR THERAPIES, INC.
Improving and extending lives of patients with CNS disease
Newburyport, United States · Founded 2024 · $21.0M raised
- Headquarters
- Newburyport, Massachusetts
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- encleartherapies.com
- Total Funding
- $21.0M
- Last Round
- $5.0M GrantSep 2024
- Rounds
- 4
About
EnClear Therapies is a neurotechnology company developing the proprietary EnTrega CSF Platform for precision dosing and filtration of cerebrospinal fluid to treat CNS diseases including ALS, PSP, Alzheimer's, and neuro-oncology. The company has raised over $12M from investors including Dolby Family Ventures and Peter Thiel, and has received $5M+ in SBIR grants from the NIH NINDS and NCI.
Summary
ENCLEAR THERAPIES, INC. is a Biotech company based in Newburyport, United States, founded in 2024. It has raised $21.0M in total across 4 rounds, most recently a $5.0M Grant round in Sep 2024. Investors include National Cancer Institute, 20/20 HealthCare Partners and National Institute of Neurological Disorders and Stroke (NINDS).
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...